Overview

Description

  • NatureSynthetic
  • Amino Acid Sequence
    • SpeciesHuman
    • SequenceLSATPLYGNVHSW-C
    • Amino acids2 to 14

Associated products

Specifications

Our Abpromise guarantee covers the use of ab23093 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Blocking - Blocking peptide for Anti-BCOR antibody (ab5276)

  • FormLiquid
  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

General Info

  • Alternative names
    • 5830466J11Rik
    • 8430401K06Rik
    • ANOP 2
    • ANOP2
    • BCL 6 co repressor
    • BCL 6 corepressor
    • BCL 6 interacting corepressor
    • BCL-6 corepressor
    • BCL6 co repressor
    • BCL6 corepressor
    • BCL6 interacting corepressor
    • BCoR
    • BCOR_HUMAN
    • FLJ20285
    • FLJ38041
    • KIAA1575
    • MAA 2
    • MAA2
    • MCOPS 2
    • MCOPS2
    • MGC131961
    • MGC71031
    see all
  • FunctionTranscriptional corepressor. May specifically inhibit gene expression when recruited to promoter regions by sequence specific DNA-binding proteins such as BCL6 and MLLT3. This repression may be mediated at least in part by histone deacetylase activities which can associate with this corepressor. Involved in the repression of TFAP2A; impairs binding of BCL6 and KDM2B to TFAP2A promoter regions. Via repression of TFAP2A acts as a negative regulator of osteo-dentiogenic capacity in adult stem cells; the function implies inhibition of methylation on histone H3 'Lys-4' (H3K4me3) and 'Lys-36' (H3K36me2).
  • Tissue specificityUbiquitously expressed.
  • Involvement in diseaseDefects in BCOR are the cause of microphthalmia syndromic type 2 (MCOPS2) [MIM:300166]. Microphthalmia is a clinically heterogeneous disorder of eye formation, ranging from small size of a single eye to complete bilateral absence of ocular tissues (anophthalmia). In many cases, microphthalmia/anophthalmia occurs in association with syndromes that include non-ocular abnormalities. MCOPS2 is a very rare multiple congenital anomaly syndrome characterized by eye anomalies (congenital cataract, microphthalmia, or secondary glaucoma), facial abnormalities (long narrow face, high nasal bridge, pointed nose with cartilages separated at the tip, cleft palate, or submucous cleft palate), cardiac anomalies (atrial septal defect, ventricular septal defect, or floppy mitral valve) and dental abnormalities (canine radiculomegaly, delayed dentition, oligodontia, persistent primary teeth, or variable root length).
  • Sequence similaritiesBelongs to the BCOR family.
    Contains 3 ANK repeats.
  • Cellular localizationNucleus.
  • Information by UniProt

References for Human BCOR peptide (ab23093)

ab23093 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab23093.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"